New York State Common Retirement Fund
LVTX

New York State Common Retirement Fund’s LAVA Therapeutics LVTX Stock Holding History

New York State Common Retirement Fund’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,136
Closed -$208K – 3448
2021
Q2 		$208K Sell
19,136
-6,836
-26% -$84.7K ﹤0.01% 3027
2021
Q1 		$395K Buy
+25,972
New +$357K ﹤0.01% 2549

Other funds holding LVTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

New York State Common Retirement Fund's LVTX Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of LAVA Therapeutics (LVTX) in Q3 2021, closing a stake of 19,136 shares — an estimated $208K sold.

New York State Common Retirement Fund first reported a position in LVTX in Q1 2021 and held it in 2 quarters. The position peaked at $395K in Q1 2021. 19 funds tracked by Wall St. Rank hold LVTX as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining LAVA Therapeutics position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 19,136 LAVA Therapeutics shares in Q3 2021, an estimated $208K.
  • New York State Common Retirement Fund first reported a position in LAVA Therapeutics in Q1 2021 and held it in 2 quarters.
  • New York State Common Retirement Fund's LAVA Therapeutics position peaked at $395K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.